Free Trial

California Public Employees Retirement System Sells 104,488 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background
Remove Ads

California Public Employees Retirement System cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 29.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 253,087 shares of the medical instruments supplier's stock after selling 104,488 shares during the quarter. California Public Employees Retirement System owned approximately 0.13% of DENTSPLY SIRONA worth $4,804,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in XRAY. Vanguard Group Inc. raised its stake in DENTSPLY SIRONA by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after acquiring an additional 65,478 shares in the last quarter. First Eagle Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 2.5% during the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after purchasing an additional 348,532 shares in the last quarter. Nuance Investments LLC lifted its holdings in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after purchasing an additional 2,708,097 shares during the period. Cooke & Bieler LP grew its position in DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after buying an additional 1,794,391 shares in the last quarter. Finally, Pacer Advisors Inc. increased its stake in DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after buying an additional 4,473,972 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

DENTSPLY SIRONA Stock Up 0.7 %

Shares of DENTSPLY SIRONA stock traded up $0.10 during midday trading on Monday, hitting $12.87. The company's stock had a trading volume of 64,619 shares, compared to its average volume of 2,905,521. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $31.75. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $2.56 billion, a P/E ratio of -6.22, a PEG ratio of 1.80 and a beta of 0.92. The stock has a 50-day simple moving average of $16.21 and a 200-day simple moving average of $19.10.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.97%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

Insider Activity

In related news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 0.52% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on XRAY shares. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Evercore ISI reiterated an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Mizuho cut their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Finally, StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $23.33.

Read Our Latest Research Report on XRAY

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads